Koninklijke Philips reported EUR1.79B in Cash and Equivalent for its fiscal quarter ending in June of 2026.





Cash And Equivalent Change Date
Abbott USD 4.05B 1.05B Sep/2026
Baxter International USD 1.98B 175M Sep/2026
Becton, Dickinson and Co. USD 725M 17M Sep/2026
Boston Scientific USD 609M 70M Sep/2026
Danaher USD 5.68B 1.33B Sep/2026
Demant DKK 1.5B 166M Jun/2026
Dexcom USD 961.4M 143.6M Sep/2026
Edwards Lifesciences USD 3.11B 210.8M Sep/2026
Fresenius EUR 1.28B 780M Jun/2026
General Electric Aerospace USD 8.76B 581M Sep/2026
Getinge SEK 2.05B 909M Jun/2026
Globus Medical USD 441.27M 66.47M Sep/2026
GN Store Nord DKK 685M 121M Sep/2026
Hitachi JPY 1.5T 181.02B Jun/2026
Idexx Laboratories USD 197.54M 603K Sep/2026
Insulet USD 584.4M 49.5M Sep/2026
Integra LifeSciences USD 252.26M 37.85M Sep/2026
Intuitive Surgical USD 6.8B 1.83B Sep/2026
J&J USD 16.91B 3.51B Sep/2026
Koninklijke Philips EUR 1.79B 803M Jun/2026
Medtronic USD 1.69B 258M Jun/2026
Philips EUR 2.75B 962M Sep/2026
ResMed USD 1.01B 458.49M Sep/2026
Steris USD 482.3M 42.7M Jun/2026
Stryker USD 3.27B 120M Sep/2026
Teleflex USD 430.46M 130.31M Sep/2026
Terumo JPY 314.63B 34.14B Jun/2026
Zimmer Biomet Holdings USD 399.9M 10.1M Sep/2026